A Randomized, Controlled Study of the Safety and Preventive Efficacy of Oral Ganciclovir When Used in Conjunction With An Intravitreal Ganciclovir Implant in the Treatment of Cytomegalovirus Retinitis

NACompletedINTERVENTIONAL
Enrollment

450

Participants

Timeline

Start Date

Not specified

Conditions
Cytomegalovirus RetinitisHIV Infections
Interventions
DRUG

Ganciclovir

Trial Locations (23)

10016

Dr Dorothy Friedberg, New York

10019

Saint Clare's Prof Office, New York

10021

New York Hosp, New York

10028

Vitreo - Retinal Consultants, New York

20036

Dr Alan Palestine, Washington D.C.

30322

Emory Eye Clinic, Atlanta

32204

Dr Michael Stewart, Jacksonville

33136

Bascom Palmer, Miami

40536

Univ of Kentucky Med Ctr, Lexington

60611

Dr David Weinberg, Chicago

75235

Univ of Texas Southwestern Med Ctr of Dallas, Dallas

77030

Baylor College of Medicine, Houston

90033

Estelle Doheny Eye Clinic, Los Angeles

90211

Dr Neil Brourman, Beverly Hills

90509

Harbor - UCLA Med Ctr, Torrance

92715

UCI College of Medicine, Irvine

93103

Dr Robert Avery, Santa Barbara

94115

Kaiser Hosp, San Francisco

Pacific Horizons Med Group, San Francisco

95128

Santa Clara Valley Med Ctr, San Jose

95819

Dr Robert T Wendel, Sacramento

98195

Univ of Washington Med Ctr, Seattle

02111

New England Med Ctr / Tufts Univ, Boston

All Listed Sponsors
lead

Roche Global Development

OTHER

NCT00002134 - A Randomized, Controlled Study of the Safety and Preventive Efficacy of Oral Ganciclovir When Used in Conjunction With An Intravitreal Ganciclovir Implant in the Treatment of Cytomegalovirus Retinitis | Biotech Hunter | Biotech Hunter